Facts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia

被引：0
|
作者：
Medeiros, Bruno C. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
ACTA HAEMATOLOGICA | 2014年 / 131卷 / 04期
关键词：
1ST RELAPSE;
D O I：
10.1159/000355134
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：200 / 201
页数：2
相关论文
共 50 条
  • [1] A long remission with fludarabine/cytarabine in relapsed acute myeloid leukemia
    Steel, E
    Henckaerts, E
    Snoeck, HW
    Bememan, ZN
    Schroyens, W
    LEUKEMIA, 2001, 15 (03) : 497 - 497
  • [2] The Combination of Fludarabine, Cytarabine and Etoposide Is an Active and Well-Tolerated Regimen in Replapsed/Refractirt Acute Myeloid Leukemia
    Aldoss, Ibrahim
    Ji, Lingyun
    Haider, Mintallah
    Pullarkat, Vinod
    ACTA HAEMATOLOGICA, 2014, 131 (04) : 202 - 207
  • [3] FLAIE (FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE) AS INDUCTION CHEMOTHERAPY OF ADULT ACUTE MYELOID LEUKEMIA. A PILOT STUDY REPORT
    Candoni, A.
    Simeone, E.
    Michelutti, A.
    Damiani, D.
    Russo, D.
    Fanin, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 123 - 123
  • [4] Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
    Krogh-Madsen, Mikkel
    Bender, Brendan
    Jensen, Morten Krogh
    Nielsen, Ove Juul
    Friberg, Lena E.
    Honore, Per Hartvig
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1155 - 1163
  • [5] Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia
    Mikkel Krogh-Madsen
    Brendan Bender
    Morten Krogh Jensen
    Ove Juul Nielsen
    Lena E. Friberg
    Per Hartvig Honoré
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1155 - 1163
  • [6] FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience
    Candoni, Anna
    Simeone, Erica
    Tiribelli, Mario
    Malagola, Michele
    Russo, Domenico
    Fanin, Renato
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (10) : 690 - 692
  • [7] Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia
    Ferrara, Felicetto
    D'Arco, Alfonso M.
    De Simone, Mariacarla
    Mele, Giuseppina
    Califano, Catello
    Pocali, Barbara
    Danise, Paolo
    Palmieri, Salvatore
    HAEMATOLOGICA, 2005, 90 (06) : 776 - 784
  • [8] AMSACRINE, CYTARABINE AND ETOPOSIDE IN THE TREATMENT OF BAD PROGNOSIS ACUTE MYELOID-LEUKEMIA
    WAHLIN, A
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1989, 6 (03): : 199 - 205
  • [9] Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia
    Shahswar, Rabia
    Beutel, Gernot
    Gabdoulline, Razif
    Schwarzer, Adrian
    Kloos, Arnold
    Koenecke, Christian
    Stadler, Michael
    Gohring, Gudrun
    Behrens, Yvonne Lisa
    Li, Zhixiong
    Dallmann, Louisa-Kristin
    Klement, Piroska
    Albert, Catherin
    Wichmann, Martin
    Alwie, Yasmine
    Benner, Axel
    Saadati, Maral
    Ganser, Arnold
    Thol, Felicitas
    Heuser, Michael
    HAEMATOLOGICA, 2024, 109 (01) : 72 - 83
  • [10] Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy
    Brian McLaughlin
    Annie Im
    Anastasios Raptis
    Mounzer Agha
    Jing-Zhou Hou
    Robert Redner
    Shrina Duggal
    Yan Lin
    Clay Smith
    Michael Boyiadzis
    International Journal of Hematology, 2012, 96 : 743 - 747
12345